A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects

Completed · Phase 2

Conditions studied: Hypocalcemia

In brief

A study to determine the effect of Zemplar on the regulation of serum calcium levels and the need for administration of elemental calcium in hypocalcemic intensive care patients

Key facts

Study ID

NCT00053378

Run by

Abbott

People needed

45

Starts

2002-01-01

Last updated by the study team

2006-08-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• ICU patients APACHE III score between 70 - 150 at screening and within 24 hours of enrollment and a whole blood ionized calcium level less than 0.90 mmol/L or corrected whole blood calcium level less than or equal to 7.5 mg/dL.

You may not qualify if…

• Serum creatinine greater than 2.5 mg/dL

Where it is running

• Merced Heart Association — Merced, California, United States
• Denver Health Medical Center — Denver, Colorado, United States
• Outcomes Research Institute — Hudson, Florida, United States
• Florida Hospital — Orlando, Florida, United States
• University of Chicago — Chicago, Illinois, United States
• Central Baptist Hospital Clinical Research Center — Lexington, Kentucky, United States
• Strong Memorial Hospital — Rochester, New York, United States
• St. Luke's Hospital — Bethlehem, Pennsylvania, United States
• Heart Care Associates — Hopewell, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.